Compile Data Set for Download or QSAR
Report error Found 36 Enz. Inhib. hit(s) with all data for entry = 12907
TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738212(N-(2-methylbenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739650(N-(2,6-dimethylbenzyl)-2-(3-(6-methylpyridin-2-yl)...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739553(N-(2,6-dimethylbenzyl)-2-(3-(pyridin-2-yl)-4-(quin...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739530(N-(2,6-difluorobenzyl)-2-(3-(6-methylpyridin-2-yl)...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739651(N-(2-ethylbenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(q...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738220(N-(2-chlorobenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739652(N-(2,6-dichlorobenzyl)-2-(3-(6-methylpyridin-2-yl)...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738218(N-(4-methylbenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738217(2-(3-(6-ethylpyridin-2-yl)-4-(quinolin-4-yl)-1H-py...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738216(N-benzyl-2-(3-(6-ethylpyridin-2-yl)-4-(quinolin-4-...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738191(N-benzyl-2-(3-(6-methylpyridin-2-yl)-4-(quinolin-4...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738218(N-(4-methylbenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738220(N-(2-chlorobenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738191(N-benzyl-2-(3-(6-methylpyridin-2-yl)-4-(quinolin-4...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739530(N-(2,6-difluorobenzyl)-2-(3-(6-methylpyridin-2-yl)...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739651(N-(2-ethylbenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(q...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738158(N-benzyl-2-(3-(pyridin-2-yl)-4-(quinolin-4-yl)-1H-...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739652(N-(2,6-dichlorobenzyl)-2-(3-(6-methylpyridin-2-yl)...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738158(N-benzyl-2-(3-(pyridin-2-yl)-4-(quinolin-4-yl)-1H-...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739653(4-((2-(3-(pyridin-2-yl)-4-(quinolin-4-yl)-1H-pyraz...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738212(N-(2-methylbenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738217(2-(3-(6-ethylpyridin-2-yl)-4-(quinolin-4-yl)-1H-py...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM739650(N-(2,6-dimethylbenzyl)-2-(3-(6-methylpyridin-2-yl)...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738224(N-(2,6-difluorobenzyl)-2-(3-(pyridin-2-yl)-4-(quin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738219(N-(2-chlorobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738215(N-(2-fluorobenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738214(N-(2-fluorobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738211(N-(2-methylbenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738210(N-(3-cyanobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin-...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738199(N-(3-chlorobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738198(N-(3-fluorobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738192(N-(3-methylbenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738176(N-(4-methylbenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738173(N-(4-bromobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin-...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738162(N-(4-chlorobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738160(N-(4-fluorobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin...)
Affinity DataIC50: 450nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent